Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

NCT05580445 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: CT-707
DRUG: Toripalimab
DRUG: Gemcitabine

Sponsor

Shouyao Holdings (Beijing) Co. LTD